Economy · News reference
Shares of semiconductor companies are trading lower amid concerns that OpenAI's Q2 earnings may weigh on AI growth. Today's Fed minutes revealed that many participants assessed that higher rates would likely be necessary if inflation did not fall.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
ACLSACMRAEHRALABAMATAMDAMKRASMLASYSAVGOAXTICBRSCOHUCRDOENTGFORMICHRINDIINTCIONQKLACKLICLRCXMKSIMTSIMXLONTOPENGQRGTISITMSMTCSTMTERTSEMUCTTVECOWOLF
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Axcelis Technologies (ACLS) Declines More Than Market: Some Information for Investors
Axcelis Technologies (ACLS) declined 3.03% to $115.56, underperforming the S&P 500's 0.48% loss. The stock has fallen 11.96% over the past month. Analysts expect upcoming earnings of $1.11 per share (down 8.26% YoY) with revenue of $230.05 million (up 7.7% YoY). Full-year estimates project earnings of $4.12 per share (down 15.57% YoY) and revenue of $883.6 million (up 5.31% YoY). ACLS holds a Zacks Rank of #3 (Hold) with a Forward P/E of 28.92, trading at a slight discount to its industry average.
Axcelis Technologies Announces Plans To Invest $35M In New Ion Implantation Equipment Manufacturing Facility In Pyeongtaek, Korea; Groundbreaking Set For October 20, Production To Begin H2 2028
Can AEHR's Diversification Strengthen Its Growth Outlook?
Aehr Test Systems has dramatically diversified its revenue streams, with AI processors and silicon photonics now driving nearly 95% of fiscal 2026 revenues, compared to over 95% EV-related SiC exposure two years prior. The company secured a $22 million follow-on order for AI processor systems in August and maintains a $100.6 million backlog with a $130-$150 million fiscal 2027 revenue outlook, though it faces intense competition from larger rivals Teradyne and FormFactor in the semiconductor test equipment market.
Corning, Cellectis, Biodexa Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures fell, with Nasdaq 100 futures down 500 points. Corning dropped 8% after a $2B offering; several other stocks also slid premarket.
This Amer Sports Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Analysts initiate: Buy—Abivax ($155), Amer Sports ($42) and more